SCHEMBL913404

SCHEMBL913404

OCC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.46
HDAC6 Q9UBN7 1/20 0.42
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KCNN4 O15554 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HIF1A Q16665 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8413148 0.88 ESR1 (0.56) KIF11HDAC6TSHRALDH1A1
SCHEMBL16508368 0.86 KCNN4 (0.50) KIF11HDAC6CYP2C19CYP2C9ALDH1A1
SCHEMBL28827440 0.86 HDAC6 (0.43) KIF11HDAC6CYP2C19CYP1A2CYP2C9
SCHEMBL8592606 0.81 KIF11 (0.60) KIF11SMN1; SMN2
SCHEMBL5838167 0.81 KIF11 (0.60) KIF11SMN1; SMN2
SCHEMBL1670181 0.80 SMN1; SMN2 (0.48) CYP2C19CYP1A2CYP2C9ALDH1A1SMN1; SMN2
SCHEMBL8413404 0.79 ALDH1A1 (0.45) KIF11HDAC6CYP2C19CYP1A2CYP2C9
SCHEMBL913229 0.78 KIF11 (0.54) KIF11CYP2C19CYP1A2CYP2C9SMN1; SMN2
Hydrochloric Acid SCHEMBL29012323 0.78 SMN1; SMN2 (0.52) CYP2C19CYP1A2CYP2C9ALDH1A1SMN1; SMN2
SCHEMBL11621984 0.78 TSHR (0.39) KIF11HDAC6CYP1A2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 260 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116870165-A Combination for the treatment of cancer and therapeutic use thereof 北京奥源和力生物技术有限公司 2023-10-13 CN claimed
US-9676904-B2 Metal alkoxide complex, catalyst composition, and production method of polycaprolactone or polylactide CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2017-06-13 US claimed
CN-105884766-A Method for synthesizing minodronate intermediate 复旦大学 2016-08-24 CN claimed
US-20140364580-A1 METAL ALKOXIDE COMPLEX, CATALYST COMPOSITION, AND PRODUCTION METHOD OF POLYCAPROLACTONE OR POLYLACTIDE CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2014-12-11 US claimed
CN-103360387-A Method for preparing compound zolpidem UNIV FUDAN 2013-10-23 CN claimed
WO-2012155932-A1 IMPROVED PROCESS FOR THE PREPARATION OF EZETIMIBE PHARMATHEN S.A. (GR) 2012-11-22 WO claimed
EP-1838678-A1 PROCESS FOR OBTAINING CIZOLIRTINE AND ITS ENANTIOMERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-10-03 EP claimed
WO-2006097121-A1 METHOD FOR PRODUCING BIPHENYL-TETRAZOLE COMPOUNDS ULKAR KIMYA SANAYII VE TICARET A.S. (TR) 2006-09-21 WO claimed
WO-2006063861-A1 PROCESS FOR OBTAINING CIZOLIRTINE AND ITS ENANTIOMERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-06-22 WO claimed
CN-1235851-C Method for producing alkenyl ethers BASF AG (DE) 2006-01-11 CN claimed
EP-0573210-B2 Pressure-sensitive record material ARJO WIGGINS LTD (GB) 2005-11-23 EP claimed
EP-1268380-B1 METHOD FOR PRODUCING ALKENYL ETHERS BASF AG (DE) 2003-09-17 EP claimed
US-20030114715-A1 Method for producing alkenyl ethers BOETTCHER ARND (DE) 2003-06-19 US claimed
EP-0573210-B1 Pressure-sensitive record material ARJO WIGGINS LTD (GB) 1998-10-28 EP claimed
US-5464803-A Chromogenic composition for use in pressure-sensitive record material comprises chromogen in vegetable oil vehicle which is high melting and solid or semisolid at ambient temperatures and free of specified ester of nonaromatic monocarboxylic acid THE WIGGINS TEAPE GROUP LIMITED (GB) 1995-11-07 US claimed
EP-0573210-A2 Pressure-sensitive record material The Wiggins Teape Group Limited (GB) 1993-12-08 EP claimed
EP-0010565-B1 PROCESS FOR PREPARING N-TRITYLIMIDAZOLE COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-11-10 EP claimed
US-4216333-A Process for preparing N-tritylimidazole compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-08-05 US claimed
EP-0010565-A1 Process for preparing N-tritylimidazole compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-05-14 EP claimed
CN-119899292-A Fluoroaryl boron salt compound dispersion system and preparation method and application thereof 中国石油化工股份有限公司 2025-04-29 CN disclosed
CN-114634483-B Antimitotic amides for the treatment of cancer and proliferative diseases 弗洛斯特生物科技有限公司 2024-08-13 CN disclosed
WO-2024150700-A1 RESIN COMPOSITION, CURED ARTICLE, MULTILAYER BODY, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING MULTILAYER BODY, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, SEMICONDUCTOR DEVICE, AND RESIN 富士フイルム株式会社 2024-07-18 WO disclosed
WO-2024143210-A1 MEMBER, METHOD FOR MANUFACTURING MEMBER, PHOTOSENSITIVE RESIN COMPOSITION, AND SEMICONDUCTOR MEMBER 富士フイルム株式会社 2024-07-04 WO disclosed
WO-2024143209-A1 METHOD FOR PRODUCING MULTILAYER BODY, PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR MEMBER 富士フイルム株式会社 2024-07-04 WO disclosed
WO-2024143212-A1 METHOD FOR MANUFACTURING LAMINATE, METHOD FOR MANUFACTURING SEMICONDUCTOR MEMBER, PHOTOSENSITIVE RESIN COMPOSITION, LAMINATE, SEMICONDUCTOR MEMBER, AND RESIN COMPOSITION 富士フイルム株式会社 2024-07-04 WO disclosed
WO-2024143211-A1 MEMBER, METHOD FOR MANUFACTURING MEMBER, PHOTOSENSITIVE RESIN COMPOSITION, AND SEMICONDUCTOR MEMBER 富士フイルム株式会社 2024-07-04 WO disclosed
WO-2024101266-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-05-16 WO disclosed
WO-2024101295-A1 PRODUCTION METHOD FOR CURED PRODUCT, PRODUCTION METHOD FOR LAMINATE, PRODUCTION METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-05-16 WO disclosed
WO-2024095885-A1 RESIN COMPOSITION, CURED OBJECT, LAYERED OBJECT, METHOD FOR PRODUCING CURED OBJECT, METHOD FOR PRODUCING LAYERED OBJECT, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-05-10 WO disclosed
WO-2024095884-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-05-10 WO disclosed
WO-2024090460-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, PRODUCTION METHOD FOR CURED PRODUCT, PRODUCTION METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-05-02 WO disclosed
WO-2024071237-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-04-04 WO disclosed
WO-2024070963-A1 FILM PRODUCTION METHOD, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT PRODUCTION METHOD, CURED PRODUCT, AND LAMINATE 富士フイルム株式会社 2024-04-04 WO disclosed
WO-2024071380-A1 RESIN COMPOSITION, CURED OBJECT, LAYERED PRODUCT, METHOD FOR PRODUCING CURED OBJECT, METHOD FOR PRODUCING LAYERED PRODUCT, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-04-04 WO disclosed
CN-117751155-A Copolymerization of aldehydes and vinyl ethers 巴斯夫欧洲公司 2024-03-22 CN disclosed
WO-2024053655-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-14 WO disclosed
WO-2024048605-A1 RESIN COMPOSITION, CURED PRODUCT, LAYERED BODY, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAYERED BODY, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-07 WO disclosed
WO-2024048604-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-07 WO disclosed
WO-2024048435-A1 RESIN COMPOSITION, CURED ARTICLE, LAMINATE, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-07 WO disclosed
WO-2024048436-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-07 WO disclosed
WO-2024048603-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE 富士フイルム株式会社 2024-03-07 WO disclosed
EP-4317287-A1 NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, AND SEMICONDUCTOR DEVICE FUJIFILM Corporation (JP) 2024-02-07 EP disclosed
CN-117440986-A Polyisobutene having a high content of specific double bond isomers 巴斯夫欧洲公司 2024-01-23 CN disclosed
CN-111448323-B Precision guided multifunctional therapeutic antibodies 长源赋能(上海)生命科技有限公司 2023-12-01 CN disclosed
CN-113698514-B Process for preparing highly reactive isobutylene homo-or copolymers 巴斯夫欧洲公司 2023-11-10 CN disclosed
CN-116870165-A Combination for the treatment of cancer and therapeutic use thereof 北京奥源和力生物技术有限公司 2023-10-13 CN disclosed
CN-110753756-B Immunomodulatory polynucleotides and uses thereof 华普生物技术(河北)股份有限公司 2023-09-01 CN disclosed
CN-116075531-A Process for preparing highly reactive isobutylene homo-or copolymers 巴斯夫欧洲公司 2023-05-05 CN disclosed
CN-110997737-B Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2023-03-14 CN disclosed
CN-108602913-B Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2022-07-08 CN disclosed
CN-107709354-B Integrin targeting proteins and methods of use thereof 乔治亚州立大学研究基金会 2022-01-04 CN disclosed
CN-113811299-A Immunomodulatory compositions and methods for treating cancer 博笛生物科技有限公司 2021-12-17 CN disclosed
CN-113698514-A Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2021-11-26 CN disclosed
CN-108602914-B Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2021-09-24 CN disclosed
WO-2020046403-A1 NOVEL PROCESS FOR THE PREPARATION OF ENANTIOPURE 3- ENANTIOPURE 3-AMINO TETRAHYDROFURAN AND ITS SALTS MAJEED MUHAMMED (US) 2020-03-05 WO disclosed
US-10421734-B1 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts SAMI LABS LIMITED (IN) 2019-09-24 US disclosed
US-10280194-B2 Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby CLEMSON UNIVERSITY (US) 2019-05-07 US disclosed
CN-109415472-A ultraviolet-curable silicone composition and cured product thereof 信越化学工业株式会社 2019-03-01 CN disclosed
CN-108504298-A Adhesive tape 日东电工株式会社 2018-09-07 CN disclosed
CN-108291116-A The manufacturing method of Thermocurable adhesive sheet and semiconductor device 迪睿合株式会社 2018-07-17 CN disclosed
US-10023752-B2 Conductive material and substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
CN-105273498-B Light curable type ink composition, recording method and device, light-cured type composition for ink jet recording and ink jet recording method 精工爱普生株式会社 2018-06-15 CN disclosed
EP-3310855-A1 DISINTEGRATABLE POLYMER COMPOSITES FOR DOWNHOLE TOOLS Baker Hughes, a GE company, LLC (US) 2018-04-25 EP disclosed
CN-105884766-B A kind of method for synthesizing minot phosphoric acid intermediate 复旦大学 2017-11-24 CN disclosed
US-9676904-B2 Metal alkoxide complex, catalyst composition, and production method of polycaprolactone or polylactide CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2017-06-13 US disclosed
US-20170137460-A1 Short Chain PEGylation of Amino Acid Monomers Glutamine, Lysine and Peptides Formed Thereby CLEMSON UNIVERSITY 2017-05-18 US disclosed
US-20170130070-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
EP-3151828-A1 SHORT CHAIN PEGYLATION OF AMINO ACID MONOMERS GLUTAMINE AND LYSINE AND PEPTIDES FORMED THEREBY Clemson University (US) 2017-04-12 EP disclosed
EP-2488522-B1 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN HANMI SCIENCE CO LTD (KR) 2017-02-15 EP disclosed
WO-2016204886-A1 DISINTEGRATABLE POLYMER COMPOSITES FOR DOWNHOLE TOOLS BAKER HUGHES INCORPORATED (US) 2016-12-22 WO disclosed
CN-103360387-B A kind of method preparing compound zolpidem 江苏豪森药业集团有限公司 2016-12-14 CN disclosed
CN-106164190-A Coating fluid that transparent coating is formed and manufacture method, organic resin dispersion sol and the base material with transparent coating and manufacture method thereof 日挥触媒化成株式会社 2016-11-23 CN disclosed
US-9499638-B2 Polysaccharide derivative and separating agent for optical isomer containing the same DAICEL CORPORATION (JP) 2016-11-22 US disclosed
CN-105884766-A Method for synthesizing minodronate intermediate 复旦大学 2016-08-24 CN disclosed
WO-2015191433-A1 SHORT CHAIN PEGYLATION OF AMINO ACID MONOMERS GLUTAMINE AND LYSINE AND PEPTIDES FORMED THEREBY CLEMSON UNIVERSITY (US) 2015-12-17 WO disclosed
CN-103265528-B Esomeprazole magnesium preparation method HUNAN QIANJIN XIANGJIANG PHARM CO LTD 2015-05-06 CN disclosed
US-8987499-B2 Compositions produced from plasticiser esters EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-03-24 US disclosed
US-20140364580-A1 METAL ALKOXIDE COMPLEX, CATALYST COMPOSITION, AND PRODUCTION METHOD OF POLYCAPROLACTONE OR POLYLACTIDE CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2014-12-11 US disclosed
CN-102596956-B Novel method for preparing entecavir and intermediate used therein HANMI HOLDINGS CO LTD 2014-09-24 CN disclosed
US-8829227-B2 Plasticiser esters EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-09-09 US disclosed
US-20140128597-A1 POLYSACCHARIDE DERIVATIVE AND SEPARATING AGENT FOR OPTICAL ISOMER CONTAINING THE SAME DAICEL CORPORATION (JP) 2014-05-08 US disclosed
US-8569491-B2 Method for preparing entecavir and intermediate used therein HANMI SCIENCE CO., LTD (KR) 2013-10-29 US disclosed
CN-103360387-A Method for preparing compound zolpidem UNIV FUDAN 2013-10-23 CN disclosed
CN-103265528-A Esomeprazole magnesium preparation method HUNAN QIANJIN XIANGJIANG PHARM CO LTD 2013-08-28 CN disclosed
EP-2451772-B1 METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS HENKEL AG & CO KGAA (DE) 2013-07-24 EP disclosed
EP-1907348-B1 PLASTICISER ESTERS EXXONMOBIL CHEM PATENTS INC (US) 2013-02-13 EP disclosed
US-8329936-B2 Method for producing cyanoacrylate esters in the presence of transition metal catalysts HENKEL AG & CO. KGAA (DE) 2012-12-11 US disclosed
WO-2012155932-A1 IMPROVED PROCESS FOR THE PREPARATION OF EZETIMIBE PHARMATHEN S.A. (GR) 2012-11-22 WO disclosed
WO-2012140490-A2 PROCESS FOR PREPARING QUINOLINE DERIVATIVE AUROBINDO PHARMA LIMITED (IN) 2012-10-18 WO disclosed
CN-101184721-B Plasticiser esters EXXON MOBIL CHEM PATENTS INC 2012-09-12 CN disclosed
EP-2488522-A2 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN Hanmi Holdings Co., Ltd. (KR) 2012-08-22 EP disclosed
US-20120203021-A1 METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS HENKEL AG & CO. KGAA (DE) 2012-08-09 US disclosed
US-20120202998-A1 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN HANMI HOLDINGS CO., LTD. (KR) 2012-08-09 US disclosed
CN-102596956-A Novel method for preparing entecavir and intermediate used therein HANMI HOLDINGS CO LTD 2012-07-18 CN disclosed
CN-101955470-B Potentiators of glutamate receptors LILLY CO ELI 2012-06-13 CN disclosed
EP-2451772-A1 METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS Henkel AG & Co. KGaA (DE) 2012-05-16 EP disclosed
CN-101263429-B pattern forming method using film-forming composition TOKYO OHKA KOGYO CO.,LTD. (JP) 2011-12-28 CN disclosed
US-8017620-B2 Dutpase inhibitors MEDIVIR AB (SE) 2011-09-13 US disclosed
WO-2011101281-A1 METHOD FOR PRODUCING HIGHLY REACTIVE ISOBUTENE HOMO OR COPOLYMERS BASF SE (DE) 2011-08-25 WO disclosed
US-20110147650-A1 Compositions Produced From Plasticiser Esters EXXONMOBIL CHEMICAL PATENTS AINC. 2011-06-23 US disclosed
WO-2011046303-A2 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN HANMI HOLDINGS CO., LTD. (KR) 2011-04-21 WO disclosed
US-7919649-B2 Plasticiser esters EXXONMOBILE CHEMICAL PATENTS INC. (US) 2011-04-05 US disclosed
US-20110021459-A1 DUTPASE INHIBITORS MEDIVIR AB (SE) 2011-01-27 US disclosed
WO-2011003768-A1 METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS HENKEL AG & CO. KGAA (DE) 2011-01-13 WO disclosed
WO-2011003767-A2 METHOD FOR TRANSESTERIFICATION USING AN INDUCTIVELY HEATED HEATING MEDIUM HENKEL AG & CO. KGAA (DE) 2011-01-13 WO disclosed
US-7795270-B2 DUTPase inhibitors MEDIVIR AB (SE) 2010-09-14 US disclosed
EP-1152010-B1 Oligonucleotide labeling reactants and their use WALLAC OY (FI) 2010-04-21 EP disclosed
US-20100075924-A1 DUTPASE INHIBITORS MEDIVIR AB (SE) 2010-03-25 US disclosed
CN-100588654-C Method for producing ring carbonic acid ester with hydroxyl ion liquid INST PROCESS ENG CAS 2010-02-10 CN disclosed
CN-101595167-A Printing plate material is used resin and is used the planographic printing plate material of this resin KONICA MINOLTA MED & GRAPHIC (JP) 2009-12-02 CN disclosed
US-7601702-B2 Dutpase Inhibitors MEDIVIR AB (SE) 2009-10-13 US disclosed
CN-101542391-A Lithographic printing plate material KONICA MINOLTA MED & GRAPHIC (JP) 2009-09-23 CN disclosed
US-20090155546-A1 FILM-FORMING COMPOSITION, METHOD FOR PATTERN FORMATION, AND THREE-DIMENSIONAL MOLD TOKYO OHKA KOGYO CO., LTD. (JP) 2009-06-18 US disclosed
US-7534794-B2 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases BIOVITRUM AB (SE) 2009-05-19 US disclosed
US-7531573-B2 potent, selective and safe inhibitors of the Ca2+-activated potassium channel CHILDREN'S MEDICAL CENTER CORPORATION (US) 2009-05-12 US disclosed
US-7531573-B2 potent, selective and safe inhibitors of the Ca2+-activated potassium channel CHILDREN'S MEDICAL CENTER CORPORATION (US) 2009-05-12 US disclosed
US-20080312183-A1 Dutpase Inhibitors MEDIVIR AB (SE) 2008-12-18 US disclosed
US-20080300216-A1 Dutpase Inhibitors MEDIVIR AB (SE) 2008-12-04 US disclosed
US-20080275267-A1 Benzoates, phthalates, adipates, cyclohexanoates, cyclohexandioates or trimellitates esterified in the presence of a titanium alcoholate catalyst, are purified by treating with less than a stoichiometric amount of sodium or potassium hydroxide; improved storage stability in the presence of an antioxidant EXXONMOBIL CHEMICAL PATENTS INC. 2008-11-06 US disclosed
CN-101263429-A Film-forming composition, pattern-forming method using the same, and three-dimensional mold TOKYO OHKA KOGYO CO LTD (JP) 2008-09-10 CN disclosed
CN-101184721-A Plasticiser esters EXXONMOBIL CHEM PATENTS INC (US) 2008-05-21 CN disclosed
EP-1907348-A1 PLASTICISER ESTERS ExxonMobil Chemical Patents Inc. (US) 2008-04-09 EP disclosed
US-7355036-B2 Two-stage protective groups for the synthesis of biopolymers FEBIT AG (DE) 2008-04-08 US disclosed
CN-101130537-A Method for producing ring carbonic acid ester with hydroxyl ion liquid INST PROCESS ENG CAS (CN) 2008-02-27 CN disclosed
EP-1838678-A1 PROCESS FOR OBTAINING CIZOLIRTINE AND ITS ENANTIOMERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-10-03 EP disclosed
EP-1828175-A2 PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-09-05 EP disclosed
WO-2007096726-A2 PROCESS FOR THE PREPARATION OF A GLUCOSE DERIVATIVE EMCURE PHARMACEUTICALS LIMITED (IN) 2007-08-30 WO disclosed
US-20060270868-A1 Benzoates, phthalates, adipates, cyclohexanoates, cyclohexandioates or trimellitates esterified in the presence of a titanium alcoholate catalyst, are purified by treating with less than a stoichiometric amount of sodium or potassium hydroxide; improved storage stability in the presence of an antioxidant EXXONMOBIL CHEMICAL PATENTS INC. 2006-11-30 US disclosed
WO-2006125670-A1 PLASTICISER ESTERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-11-30 WO disclosed
WO-2006097121-A1 METHOD FOR PRODUCING BIPHENYL-TETRAZOLE COMPOUNDS ULKAR KIMYA SANAYII VE TICARET A.S. (TR) 2006-09-21 WO disclosed
EP-1701727-A1 DUTPASE INHIBITORS Medivir Aktiebolag (SE) 2006-09-20 EP disclosed
EP-1701952-A1 DUTPASE INHIBITORS Medivir Aktiebolag (SE) 2006-09-20 EP disclosed
US-7071180-B2 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases BIOVITRUM AB (SE) 2006-07-04 US disclosed
WO-2006063860-A2 PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-06-22 WO disclosed
WO-2006063861-A1 PROCESS FOR OBTAINING CIZOLIRTINE AND ITS ENANTIOMERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-06-22 WO disclosed
US-20060094894-A1 Acylated esters DAY JAMES F 2006-05-04 US disclosed
CN-1242995-C Novel compounds, their use and preparation BIOWHEAT RHOM AB (SE) 2006-02-22 CN disclosed
CN-1235851-C Method for producing alkenyl ethers BASF AG (DE) 2006-01-11 CN disclosed
EP-1178973-B1 PYRAZINYL-PIPERAZINE- COMPOUNDS, THEIR USE AND PREPARATION BIOVITRUM AB (SE) 2005-12-21 EP disclosed
EP-0573210-B2 Pressure-sensitive record material ARJO WIGGINS LTD (GB) 2005-11-23 EP disclosed
US-6955712-B2 Proton-conducting polymer with acid groups in side chains, preparation method thereof, polymer membrane manufactured using the polymer, and fuel cell using the polymer membrane SAMSUNG SDI CO., LTD. (KR) 2005-10-18 US disclosed
US-6949639-B1 Oligonucleotide labeling reactants and their use WALLAC OY (FI) 2005-09-27 US disclosed
WO-2005066160-A1 DUTPASE INHIBITORS MEDIVIR AB (SE) 2005-07-21 WO disclosed
WO-2005065689-A1 DUTPASE INHIBITORS MEDIVIR AB (SE) 2005-07-21 WO disclosed
US-20040260080-A1 Oligonucleotide labeling reactants and their use HOVINEN JARI (FI) 2004-12-23 US disclosed
US-20040242554-A1 CERTAIN ARYLALIPHATIC AND HETEROARYL-ALIPHATIC PIPERAZINYL PYRAZINES AND THEIR USE IN THE TREATMENT OF SEROTONIN-RELATED DISEASES BIOVITRUM, AB, A STOCKHOLM, SWEDEN CORPORATION 2004-12-02 US disclosed
US-20040197851-A1 Two-stage protective groups for the synthesis of biopolymers MR. CHRISTOPHER SEAGON, ESQ. (DE) 2004-10-07 US disclosed
US-6794546-B2 REACTION OF CORRESPONDING OH, SH OR NH COMPOUND WITH AN ACETYLENE IN LIQUID PHASE IN PRESENCE OF BASIC ALKALI OR ALKALINE EARTH METAL COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2004-09-21 US disclosed
US-20040097695-A1 Proton-conducting polymer with acid groups in side chains, preparation method thereof, polymer membrane manufactured using the polymer, and fuel cell using the polymer membrane SAMSUNG SDI CO., LTD. (KR) 2004-05-20 US disclosed
US-6695977-B2 LIQUID CRYSTALLINE MIXTURE BASF AKTIENGESELLSCHAFT (DE) 2004-02-24 US disclosed
US-20040002498-A1 Tricyclic compounds useful as HIV reverse transcriptase inhibitors JOHNSON BARRY L (US) 2004-01-01 US disclosed
US-20030207400-A1 Vectors for dna delivery BIANCHI ELISABETTA (IT) 2003-11-06 US disclosed
CN-1444552-A Method for producing alkenyl ethers BASF AG (DE) 2003-09-24 CN disclosed
EP-1268380-B1 METHOD FOR PRODUCING ALKENYL ETHERS BASF AG (DE) 2003-09-17 EP disclosed
US-6593337-B1 pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent. BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-07-15 US disclosed
US-20030114715-A1 Method for producing alkenyl ethers BOETTCHER ARND (DE) 2003-06-19 US disclosed
US-20030105354-A1 Reaction of corresponding OH, SH or NH compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds BASF AKTIENGESELLSCHAFT (DE) 2003-06-05 US disclosed
US-20030092694-A1 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases BIOVITRUM, AB, A STOCKHOLM, SWEDEN CORPORATION 2003-05-15 US disclosed
EP-1301459-A2 OPTIMIZED CATALYST ADDITION TO ENHANCE ESTERIFICATION CATALYST PERFORMANCE ExxonMobil Chemical Patents Inc. (US) 2003-04-16 EP disclosed
EP-1290198-A2 VECTORS FOR DNA DELIVERY ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2003-03-12 EP disclosed
EP-1268380-A1 METHOD FOR PRODUCING ALKENYL ETHERS BASF AKTIENGESELLSCHAFT (DE) 2003-01-02 EP disclosed
US-6465467-B1 DISEASES RELATED TO THE 5-HT2C RECEPTOR, ESPECIALLY EATING, MEMORY, MOOD, URINARY AND ANXIETY DISORDERS, SCHIZOPHRENIA, PAIN, SEXUAL DYSFUNCTIONS BIOVITRUM AB (SE) 2002-10-15 US disclosed
CN-1360583-A Novel compounds, their use and preparation BIOWHEAT RHOM AB (SE) 2002-07-24 CN disclosed
EP-1222186-A2 CONDENSED NAPHTHYRIDINES AS HIV REVERSE TRANSCRIPTASE INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2002-07-17 EP disclosed
EP-0874853-B1 PROCESS FOR PREPARATION OF CEFDINIR HANMI PHARMACEUTICAL CO LTD (KR) 2002-06-05 EP disclosed
US-6355817-B1 REACTING ALCOHOL WITH CARBONYL-LIKE COMPOUND IN PRESENCE OF FIRST AMOUNT OF FIRST ESTERIFICATION CATALYST, ADDING SECOND AMOUNT OF SECOND ESTERIFICATION CATALYST TO REACTION MIXTURE AT SOME TIME AFTER INITIATION OF FIRST STEP EXXONMOBIL CHEMICAL PATENTS INC. 2002-03-12 US disclosed
EP-1178973-A2 NOVEL COMPOUNDS, THEIR USE AND PREPARATION Pharmacia AB (SE) 2002-02-13 EP disclosed
WO-2002006204-A2 OPTIMIZED CATALYST ADDITION TO ENHANCE ESTERIFICATION CATALYST PERFORMANCE EXXONMOBIL CHEMICAL PATENTS, INC. (US) 2002-01-24 WO disclosed
EP-0680463-B2 PROCESS FOR THE PRODUCTION OF PLASTICIZER AND POLYOL ESTERS EXXONMOBIL CHEM PATENTS INC (US) 2001-12-19 EP disclosed
WO-2001088160-A2 VECTORS FOR DNA DELIVERY ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI, S.P.A. (IT) 2001-11-22 WO disclosed
EP-1152010-A2 Oligonucleotide labeling reactants and their use WALLAC OY (FI) 2001-11-07 EP disclosed
EP-0786699-B1 Positive photoresist composition FUJI PHOTO FILM CO LTD (JP) 2001-10-31 EP disclosed
WO-2001077051-A1 METHOD FOR PRODUCING ALKENYL ETHERS BASF AKTIENGESELLSCHAFT (DE) 2001-10-18 WO disclosed
WO-2001029037-A2 CONDENSED NAPHTHYRIDINES AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2001-04-26 WO disclosed
WO-2000076984-A2 NOVEL COMPOUNDS, THEIR USE AND PREPARATION BIOVITRUM AB (SE) 2000-12-21 WO disclosed
US-6093814-A A VERY PURE, CRYSTALLINE INTERMEDIATE BY REACTING A 2-ETHYLENE-6-AMINO-3-CEPHEM WITH A TRITYL-PROTECTED REACTIVE ESTER OF AN (2-AMINOTHIAZOL-4-YL)-,Z-CARBONYL-OXIME USING DIMETHYLACETAMIDE AND TOLUENESULFONIC ACID; DEPROTECTION HANMI PHARMACEUTICAL CO., LTD. (KR) 2000-07-25 US disclosed
US-5948587-A MIXTURE OF ALKALI-SOLUBLE NOVOLAK, 1,2-NAPHTHOQUINONEDIAZIDESULFONIC ESTER AND PHENOLIC COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1999-09-07 US disclosed
US-5853949-A Method of synthesizing polyphenol compound and positive working photoresist composition comprising polyphenol compound FUJI PHOTO FILM CO., LTD. (JP) 1998-12-29 US disclosed
EP-0874853-A1 PROCESS FOR PREPARATION OF CEFDINIR HANMI PHARMACEUTICAL CO.,LTD. (KR) 1998-11-04 EP disclosed
EP-0573210-B1 Pressure-sensitive record material ARJO WIGGINS LTD (GB) 1998-10-28 EP disclosed
EP-0680463-B1 PROCESS FOR THE PRODUCTION OF PLASTICIZER AND POLYOL ESTERS EXXON CHEMICAL PATENTS INC (US) 1998-06-10 EP disclosed
EP-0766139-B1 Positive working photoresist composition FUJI PHOTO FILM CO LTD (JP) 1998-03-25 EP disclosed
US-5683851-A THYMOL OR ISOTHYMOL PHENOLIC RESIN, NAPHTHOQUINONEDIAZIDESULFONATE, LOW MOLECULAR WEIGHT PHENOLIC POLYHYDROXIDE FUJI PHOTO FILM CO., LTD. (JP) 1997-11-04 US disclosed
US-5663164-A CEPHALOSPORIN ANTIBIOTICS AS BACTERICIDES ROUSSEL UCLAF (FR) 1997-09-02 US disclosed
EP-0787120-A1 PREPARATION OF PLASTICIZER ESTERS FROM PHTHALIC ANHYDRIDE RESIDUE EXXON CHEMICAL PATENTS INC. (US) 1997-08-06 EP disclosed
EP-0786699-A1 Positive photoresist composition Fuji Photo Film Co., Ltd. (JP) 1997-07-30 EP disclosed
WO-1997024358-A1 PROCESS FOR PREPARATION OF CEFDINIR HANMI PHARMACEUTICAL CO., LTD. (KR) 1997-07-10 WO disclosed
US-5620828-A Positive photoresist composition containing quinonediazide esterification product, novolak resin and pocyhydroxy alkali dissolution accelerator FUJI PHOTO FILM CO., LTD. (JP) 1997-04-15 US disclosed
EP-0766139-A1 Positive working photoresist composition FUJI PHOTO FILM CO., LTD. (JP) 1997-04-02 EP disclosed
EP-0520639-B1 Solvent compositions for use in pressure-sensitive copying paper WIGGINS TEAPE GROUP LTD (GB) 1996-12-18 EP disclosed
US-5552365-A SUPPORT CARRYING A MICROENCAPSULATED COLOR DONOR DISSOLVED IN A SOLVENT BAYER AKTIENGESELLSCHAFT (DE) 1996-09-03 US disclosed
US-5534652-A Preparation of plasticizer esters from phthalic anhydride residue EXXON CHEMICAL PATENTS INC. (ECPI) (US) 1996-07-09 US disclosed
US-5532405-A MONITORING CONCENTRATION OF LOWER BOILING ALCOHOL SO THAT MORE MAY BE ADDED TO MAINTAIN PREDETERMINED CONCENTRATION EXXON CHEMICAL PATENTS INC. (US) 1996-07-02 US disclosed
WO-1996011903-A1 PREPARATION OF PLASTICIZER ESTERS FROM PHTHALIC ANHYDRIDE RESIDUE EXXON CHEMICAL PATENTS INC. (US) 1996-04-25 WO disclosed
WO-1996002489-A1 PREPARATION OF ESTERS BY THE STAGED ADDITION OF THE LOWER BOILING POINT COMPONENT OF MIXED ALCOHOLS OR ACIDS EXXON CHEMICAL PATENTS INC. (US) 1996-02-01 WO disclosed
CN-1030768-C Primidine derivatives, process for preparing same and inhibitor for androgen OTSUKA PHARMA CO LTD (JP) 1996-01-24 CN disclosed
EP-0574632-B1 Preparation of carboxylic acid esters ROHM & HAAS (US) 1996-01-03 EP disclosed
US-5472489-A Mixture of vegetable oil and fatty acid ester THE WIGGINS TEAPE GROUP LIMITED (GB) 1995-12-05 US disclosed
WO-1995029888-A1 PREPARATION OF PLASTICIZER OR POLYOL ESTERS BY THE STAGED ADDITION OF THE LOWER BOILING POINT REACTANT EXXON CHEMICAL PATENTS INC. (US) 1995-11-09 WO disclosed
WO-1995029912-A1 ERGOLINE DERIVATIVES AS ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-11-09 WO disclosed
EP-0680463-A1 PROCESS FOR THE PRODUCTION OF PLASTICIZER AND POLYOL ESTERS EXXON CHEMICAL PATENTS INC. (US) 1995-11-08 EP disclosed
US-5464803-A Chromogenic composition for use in pressure-sensitive record material comprises chromogen in vegetable oil vehicle which is high melting and solid or semisolid at ambient temperatures and free of specified ester of nonaromatic monocarboxylic acid THE WIGGINS TEAPE GROUP LIMITED (GB) 1995-11-07 US disclosed
US-5451592-A Angiotensin antagonist C.D. SEARLE & CO. (US) 1995-09-19 US disclosed
US-5420128-A Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-05-30 US disclosed
WO-1994017028-A1 PROCESS FOR THE PRODUCTION OF PLASTICIZER AND POLYOL ESTERS EXXON CHEMICAL PATENTS INC. (US) 1994-08-04 WO disclosed
US-5324853-A Continuous mixing and removal of water during esterification EXXON CHEMICAL PATENTS INC. (US) 1994-06-28 US disclosed
US-5281266-A Vegetable oil, mono- or di-functional ester of nonaromatic carboxylic acid THE WIGGINS TEAPE GROUP LIMITED (GB) 1994-01-25 US disclosed
EP-0574632-A1 Preparation of carboxylic acid esters ROHM AND HAAS COMPANY (US) 1993-12-22 EP disclosed
EP-0573210-A2 Pressure-sensitive record material The Wiggins Teape Group Limited (GB) 1993-12-08 EP disclosed
EP-0282365-B1 1-DETHIA-2-THIA-CEPHALOSPORANIC-ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-05-12 EP disclosed
WO-1993007162-A1 PROCESS FOR THE PREPARATION OF NUCLEOSIDE DERIVATIVES LEIRAS OY (FI) 1993-04-15 WO disclosed
US-5183930-A Partial hydrolysis of metal alkoxide with water to form oligomer which is absorbed onto a hydroxylic support ROHM AND HAAS COMPANY (US) 1993-02-02 US disclosed
EP-0220907-B1 PROCESS FOR THE PREPARATION OF 1,6-DICHLORO-1,6-DIDEOXY-BETA-D-FRUCTOFURANOSYL-4-CHLORO-4-DEOXY-ALPHA-GALACTOPYRANOSIDE McNeilab, Inc. (US) 1993-01-20 EP disclosed
EP-0520639-A1 Solvent compositions for use in pressure-sensitive copying paper The Wiggins Teape Group Limited (GB) 1992-12-30 EP disclosed
EP-0503099-A1 PYRIMIDINE DERIVATIVE, PRODUCTION THEREOF, AND ANDROGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-09-16 EP disclosed
US-5145840-A Treatment of virac and bacterial infections; aids BURROUGHS WELLCOME CO. (US) 1992-09-08 US disclosed
CN-1060844-A Pyrimidine derivatives, its method for making and inhibitor for androgen OTSUKA PHARMA CO LTD (JP) 1992-05-06 CN disclosed
EP-0307303-B1 1-[(2-Pyrimidinyl)-aminoalkyl] piperidines, their preparation and their use in therapy SYNTHELABO (FR) 1991-12-04 EP disclosed
US-5064946-A 3-azido-2,3-dideoxy-B-D-erythro-pentofuranosyl derivatives of 4(1H)-pyrimidinones; antiretroviral, anti-AIDS BURROUGHS WELLCOME CO. (US) 1991-11-12 US disclosed
US-4929621-A ANTIDEPRESSANTS, ANXIOLYTIC AGENTS SYNTHELABO (FR) 1990-05-29 US disclosed
US-4891376-A MIGRAINE SYNTHELABO (FR) 1990-01-02 US disclosed
US-4845201-A Process for producing organolanthanides, the resultant compounds and their use INSTITUT FRANCAIS DU PETROLE (FR) 1989-07-04 US disclosed
EP-0307303-A1 1-[(2-Pyrimidinyl)-aminoalkyl] piperidines, their preparation and their use in therapy SYNTHELABO (FR) 1989-03-15 EP disclosed
US-4801700-A Process for the preparation of 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α- MCNEILAB, INC. (US) 1989-01-31 US disclosed
EP-0282365-A1 1-Dethia-2-thia-cephalosporanic-acid derivatives, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1988-09-14 EP disclosed
EP-0277061-A2 Process for obtaining organolantharides, compounds so obtained and their use Institut Français du Pétrole (FR) 1988-08-03 EP disclosed
EP-0161519-B1 DERIVATIVES OF GLYCEROPHOSPHOCHOLINE AND OF GLYCEROPHOSPHOETHANOL AMINE, THEIR PREPARATION AND USE CHEMIE LINZ AKTIENGESELLSCHAFT (AT) 1988-06-29 EP disclosed
EP-0255278-A1 Synthesis of azetidinones SCHERING CORPORATION (US) 1988-02-03 EP disclosed
US-4678613-A Process for the purification of triphenylmethane compounds PMC SPECIALTIES GROUP, INC. (US) 1987-07-07 US disclosed
EP-0220907-A2 Process for the preparation of 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-galactopyranoside McNeilab, Inc. (US) 1987-05-06 EP disclosed
EP-0217580-A2 Therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1987-04-08 EP disclosed
EP-0199451-A2 Therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1986-10-29 EP disclosed
US-4584321-A DIURETICS, CHOLERETIC OR ANTILIPEMIC AGENTS, TREATMENT OF LIVER DISORDERS ISTITUTO LUSO FARMACO D'ITALIA S.P.A. (IT) 1986-04-22 US disclosed
EP-0161519-A2 Derivatives of glycerophosphocholine and of glycerophosphoethanol amine, their preparation and use CHEMIE LINZ AKTIENGESELLSCHAFT (AT) 1985-11-21 EP disclosed
US-4448446-A FORMING THE SALT AND REACTING WITH A3 BASE, DISSOLVING THE CARBINOL FORM IN AN ORGANIC SOLVENT THE SHERWIN-WILLIAMS COMPANY (US) 1984-05-15 US disclosed
EP-0010565-B1 PROCESS FOR PREPARING N-TRITYLIMIDAZOLE COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-11-10 EP disclosed
EP-0008796-B1 POLYPHOSPHAZENE POLYMERS CONTAINING ALKOXY SUBSTITUENTS CONTAINING A FULLY SUBSTITUTED CARBON IN THE BETA POSITION AND PROCESS FOR THEIR PREPARATION THE FIRESTONE TIRE & RUBBER COMPANY (US) 1982-03-24 EP disclosed
EP-0002774-B1 PROCESS FOR ACYLATING 7AMINOCEPHEM DERIVATIVES HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-23 EP disclosed
US-4264759-A Polyphosphazene polymers containing alkoxy substitutents containing a fully substituted carbon in the beta position THE FIRESTONE TIRE & RUBBER COMPANY (US) 1981-04-28 US disclosed
US-4216333-A Process for preparing N-tritylimidazole compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-08-05 US disclosed
US-4216333-A Process for preparing N-tritylimidazole compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-08-05 US disclosed
EP-0010565-A1 Process for preparing N-tritylimidazole compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-05-14 EP disclosed
EP-0008796-A1 Polyphosphazene polymers containing alkoxy substituents containing a fully substituted carbon in the beta position and process for their preparation THE FIRESTONE TIRE & RUBBER COMPANY (US) 1980-03-19 EP disclosed
US-4172075-A Fluoro-steroids and processes for their manufacture CIBA-GEIGY CORPORATION (US) 1979-10-23 US disclosed
EP-0002774-A1 Process for acylating 7aminocephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-11 EP disclosed
US-4159981-A CYCLIC POLYPEPTIDES, DEETHERIFICATION, DEESTERIFICATION CIBA-GEIGY CORPORATION (US) 1979-07-03 US disclosed
US-4145414-A ANTIVIRAL, IMMUNOSUPPRESSIVE, ANTILEUKEMIA THE UPJOHN COMPANY (US) 1979-03-20 US disclosed
US-4117142-A DISUBSTITUTED TRIPHENYLMETHYLMIDAZOLES FOR TREATING MYCOTIC INFECTIONS BAYER AKTIENGESELLSCHAFT (DE) 1978-09-26 US disclosed
US-4117142-A DISUBSTITUTED TRIPHENYLMETHYLMIDAZOLES FOR TREATING MYCOTIC INFECTIONS BAYER AKTIENGESELLSCHAFT (DE) 1978-09-26 US disclosed
US-4096324-A ANTI-VIRAL, ANTILEUKEMIA THE UPJOHN COMPANY (US) 1978-06-20 US disclosed
US-4092310-A Difluorosteroids and processes for their manufacture CIBA-GEIGY CORPORATION (US) 1978-05-30 US disclosed
US-4073901-A Metal complexes of N-trityl-azoles for combatting fungi BAYER AKTIENGESELLSCHAFT (DT) 1978-02-14 US disclosed
US-4052409-A ANTIMYCOTIC BAYER AKTIENGESELLSCHAFT (DT) 1977-10-04 US disclosed
US-4052409-A ANTIMYCOTIC BAYER AKTIENGESELLSCHAFT (DT) 1977-10-04 US disclosed
US-4052421-A 13-ETHINYL-STEROIDS AND PROCESSES FOR THEIR MANUFACTURE CIBA-GEIGY CORPORATION (US) 1977-10-04 US disclosed
US-4032550-A IMMOBILIZED SUPPORTED TRANSITION METAL CATALYST EMERY INDUSTRIES, INC. (US) 1977-06-28 US disclosed
US-4001229-A ALKANESULFONAMIDO TRIPHENYLETHYLENES MEAD JOHNSON & COMPANY (US) 1977-01-04 US disclosed
US-4001229-A ALKANESULFONAMIDO TRIPHENYLETHYLENES MEAD JOHNSON & COMPANY (US) 1977-01-04 US disclosed
US-3960910-A Process for the purification of gas streams TENNECO CHEMICALS, INC. (US) 1976-06-01 US disclosed
US-3934008-A PEPTIDES, HYPOCALCAEMIC CIBA-GEIGY CORPORATION (US) 1976-01-20 US disclosed
US-3934008-A PEPTIDES, HYPOCALCAEMIC CIBA-GEIGY CORPORATION (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040197851-A1 Two-stage protective groups for the synthesis of biopolymers CTRB2, OGG1, CPB2 KIF11 4174/4885HDAC6 2953/4885CYP2C19 3058/4885
US-10280194-B2 Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby GLUL, ASNS, ARGLU1 KIF11 571/4885HDAC6 2043/4885CYP2C19 4122/4885
US-20170137460-A1 Short Chain PEGylation of Amino Acid Monomers Glutamine, Lysine and Peptides Formed Thereby GLUL, ASNS, ARGLU1 KIF11 571/4885HDAC6 2043/4885CYP2C19 4122/4885
US-20030092694-A1 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases HTR2C, HTR3C, HTR2A KIF11 4259/4885HDAC6 730/4885CYP2C19 231/4885
US-20040242554-A1 CERTAIN ARYLALIPHATIC AND HETEROARYL-ALIPHATIC PIPERAZINYL PYRAZINES AND THEIR USE IN THE TREATMENT OF SEROTONIN-RELATED DISEASES HTR2C, HTR3C, HTR2A KIF11 4162/4885HDAC6 652/4885CYP2C19 215/4885
US-20120203021-A1 METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS MMAB, COASY, HACL2 KIF11 3782/4885HDAC6 4620/4885CYP2C19 257/4885
US-20080300216-A1 Dutpase Inhibitors DUT, DHODH, POLR2H KIF11 4014/4885HDAC6 2936/4885CYP2C19 1649/4885
US-20080312183-A1 Dutpase Inhibitors DUT, DHODH, RNASEH1 KIF11 2729/4885HDAC6 3084/4885CYP2C19 1939/4885
US-20040260080-A1 Oligonucleotide labeling reactants and their use SSU72, LIG4, NSUN2 KIF11 1635/4885HDAC6 1816/4885CYP2C19 1603/4885
US-20110021459-A1 DUTPASE INHIBITORS DUT, DHODH, NAT10 KIF11 2686/4885HDAC6 2753/4885CYP2C19 1934/4885
US-20120202998-A1 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN ENTPD5, ENTPD8, ENTPD3 KIF11 3182/4885HDAC6 2649/4885CYP2C19 881/4885
US-20100075924-A1 DUTPASE INHIBITORS DUT, DHODH, CCNO KIF11 3964/4885HDAC6 2737/4885CYP2C19 2013/4885
US-10421734-B1 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts AASDHPPT, AAAS, AADAT KIF11 4455/4885HDAC6 4831/4885CYP2C19 163/4885
US-20040002498-A1 Tricyclic compounds useful as HIV reverse transcriptase inhibitors POLRMT, TYMP, POLM KIF11 3897/4885HDAC6 2312/4885CYP2C19 368/4885
US-20030105354-A1 Reaction of corresponding OH, SH or NH compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds H1-0, HAT1, H1-3 KIF11 2001/4885HDAC6 114/4885CYP2C19 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.